Early morbimortality in autologous hematopoietic cell transplantation performed on outpatient basis in patients with autoimmune diseases: experience in 1700 patients
Autor: Juan Carlos Olivares Gazca
Publicado en: Bone Marrow Transplantation
Fecha de publicación: 22 de agosto de 2025
DOI/ISSN/ISBN: 10.1038/s41409-025-02544-y
Visualizaciones: 19
Resumen
Autologous hematopoietic cell transplantation (aHSCT) is a viable therapeutic approach in patients with autoimmune diseases. The objective was to analyze the salient features of early post-aHSCT complications when performed in the outpatient setting.